Biotech and AI

In this week’s Shard Capital Podcast, Ernst Knacke, our Head of Research, and Benny Osei, Investment Associate, discuss the broad topic of biotechnology and AI.

Together, they discuss the biggest developments in healthcare over the next decade by delving into the overlap between AI, diagnostics, drug discovery and treatment. They also discuss the big opportunities they foresee in biotech, as well as what they think are novel ideas, and whether others are just trends.

Listen in on the conversation below.

Shard Capital Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 538762). Important information: The information included is published solely for information purposes and is not to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. It does not constitute a personal recommendation as defined by the Financial Conduct Authority (FCA) or take into account the particular investment objectives, financial situations or needs of individual investors. The value of investments and any income from them can fall as well as rise. You may not get back the amount you invested. It should be remembered that past performance is not a guarantee of future performance. Every effort is made to ensure the accuracy of any information provided and no assurances or warranties are given. If you are unsure of the suitability of this product then you should contact an Independent Financial Adviser, authorised by the Financial Conduct Authority.